NFBK · As filed with the SEC
Northfield Bancorp cash flow statement, by fiscal year
The statement as Northfield Bancorp presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
Consolidated Statements of Cash Flows · USD thousands
| USD thousands | FY2025 Year ended Dec 31, 2025 | FY2024 Year ended Dec 31, 2024 | FY2023 Year ended Dec 31, 2023 | FY2022 Year ended Dec 31, 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net income | 796 | 29,945 | 37,669 | 61,119 |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Provision for credit losses | 7,402 | 4,281 | 1,353 | 4,482 |
| Goodwill impairment | 41,012 | — | — | — |
| ESOP and stock compensation expense | 4,994 | 4,249 | 4,365 | 4,128 |
| Depreciation | 3,197 | 3,551 | 3,678 | 3,645 |
| Amortization of premiums and deferred loan costs, net of accretion of discounts and deferred loan fees | 3,934 | 2,434 | 6,651 | 9,306 |
| Amortization of debt issuance costs | 223 | 223 | 223 | 112 |
| Amortization of intangible assets | 47 | 85 | 124 | 174 |
| Amortization of operating lease right-of-use assets | 4,768 | 4,660 | 4,731 | 4,626 |
| Income on bank-owned life insurance | (7,069) | (4,216) | (3,631) | (3,414) |
| Net gain on sale of loans held-for-sale | — | — | — | (453) |
| (Gain) loss on sale of premises and equipment and other real estate owned, net | 0 | 3,402 | — | — |
| Net gain on sale of loans held-for-sale | 0 | (51) | (134) | — |
| Proceeds from loans held-for-sale | 0 | 673 | 1,583 | 3,544 |
| Origination of loans held-for-sale | 0 | (622) | (1,449) | (3,364) |
| Losses on available-for-sale debt securities, net | 0 | 6 | 17 | (279) |
| Gains on trading securities, net | (1,694) | (1,665) | (1,721) | 2,206 |
| Loss (gain) on sale of other real estate owned, net | — | — | 7 | (17) |
| Net sales (purchases) of trading securities | 363 | 330 | (77) | 504 |
| Increase in accrued interest receivable | (1,040) | (587) | (1,065) | (2,924) |
| Decrease (increase) in other assets | 502 | (9,428) | (8,947) | (3,673) |
| Deferred tax (benefit) provision | (984) | 1,262 | 2,919 | (625) |
| (Decrease) increase in accrued expenses and other liabilities | (2,753) | (623) | 674 | 4,234 |
| Net cash provided by operating activities | 53,698 | 31,105 | 46,970 | 83,331 |
| Cash flows from investing activities: | ||||
| Net decrease in loans receivable | 189,605 | 173,310 | 35,875 | (430,849) |
| Purchase of loans | (25,848) | (5,076) | (3,781) | (10,183) |
| Proceeds from sale of loans | — | 0 | 0 | 2,796 |
| Purchase of FHLB of New York stock | (63,761) | (25,962) | (45,318) | (44,564) |
| Redemption of FHLB of New York stock | — | — | — | 36,518 |
| Redemption of FHLB of New York stock | 53,087 | 29,735 | 36,033 | — |
| Purchases of debt securities available-for-sale | (859,650) | (1,185,265) | (73,544) | (168,973) |
| Purchases of equity securities | 0 | (3,632) | (186) | (5,046) |
| Principal payments and maturities on debt securities available-for-sale | 569,106 | 895,191 | 247,455 | 305,027 |
| Principal payments and maturities on debt securities held-to-maturity | 997 | 571 | 877 | 720 |
| Purchases of securities held-to-maturity | — | 0 | 0 | (6,237) |
| Proceeds from sale of debt securities available-for-sale | — | 0 | 0 | 41,479 |
| Proceeds from bank-owned life insurance | — | 0 | 0 | 1,526 |
| Proceeds from sale of equity securities | 9,261 | — | — | 0 |
| Proceeds from sale of premises and equipment and other real estate owned | 0 | 3,791 | 63 | 125 |
| Purchases and improvements of premises and equipment | — | — | — | (2,552) |
| Net cash acquired in business combinations | — | — | — | 0 |
| Purchases and improvements of premises and equipment | (1,150) | (1,154) | (3,605) | — |
| Net cash (used in) provided by investing activities | (128,353) | (118,491) | 193,869 | (280,213) |
| Cash flows from financing activities: | ||||
| Net (decrease) increase in deposits | (122,668) | 260,042 | (271,784) | (19,115) |
| Dividends paid | (21,152) | (21,826) | (22,795) | (24,127) |
| Exercise of stock options | 0 | 0 | 100 | 1,662 |
| Purchase of treasury stock | (15,351) | (18,677) | (37,173) | (30,881) |
| Decrease in advance payments by borrowers for taxes and insurance | (3,781) | (1,045) | (893) | 1,086 |
| Proceeds from issuance of subordinated debt, net of issuance costs | — | 0 | 0 | 60,884 |
| Proceeds from securities sold under agreements to repurchase and other borrowings | — | 892,395 | 743,553 | 282,104 |
| Repayments related to securities sold under agreements to repurchase and other borrowings | — | — | — | (120,000) |
| Proceeds from securities sold under agreements to repurchase and other borrowings | 5,336,639 | — | — | — |
| Repayments related to securities sold under agreements to repurchase and other borrowings | (5,102,825) | (1,085,265) | (468,140) | — |
| Net cash provided by (used in) financing activities | 70,862 | 25,624 | (57,132) | 151,613 |
| Net (decrease) increase in cash and cash equivalents | (3,793) | (61,762) | 183,707 | (45,269) |
| Cash and cash equivalents at beginning of year | 167,744 | 229,506 | 45,799 | 91,068 |
| Cash and cash equivalents at end of year | 163,951 | 167,744 | 229,506 | 45,799 |
| Supplemental cash flow information: | ||||
| Cash paid during the year for: | ||||
| Interest | 112,053 | 126,789 | 80,400 | 19,282 |
| Income taxes | — | 7,358 | 14,704 | 22,094 |
| Loans charged-off, net | — | — | — | 838 |
| Transfers of loans held-for-investment to loans held-for-sale, at fair value | — | — | — | 2,523 |
| Non-cash transactions: | ||||
| Loans charged-off, net | 4,441 | 6,633 | 6,435 | — |
| Transfers of loans held-for-investment to loans held-for-sale, at fair value | — | 4,897 | 0 | — |
| Transfers of loans held-for-sale at fair value to loans held-for-investment | 0 | — | 0 | 0 |
| Transfers of loans held-for-investment to other real estate owned | — | — | 0 | 0 |
| Right-of-use assets obtained in exchange for new lease liabilities | 2,786 | 2,227 | 645 | 4,983 |
| Securities available-for-sale | — | — | — | 0 |
| Loans | — | — | — | 0 |
| Accrued interest receivable | — | — | — | 0 |
| Bank-owned life insurance | — | — | — | 0 |
| Premises and equipment | — | — | — | 0 |
| Goodwill and other intangible assets | — | — | — | 0 |
| Other assets | — | — | — | 0 |
| Total non-cash assets acquired | — | — | — | 0 |
| Deposits | — | — | — | 0 |
| Other liabilities | — | — | — | 0 |
| Total non-cash liabilities assumed | — | — | — | 0 |
| Net non-cash liabilities assumed | — | — | — | 0 |
| Net cash and cash equivalents acquired | — | — | — | 0 |
| Common stock issued in acquisition | — | — | — | 0 |
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.